Literature DB >> 27984641

CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.

Qianhui Luo1, Jiankai Shen1, Yuan Yang2, Haiyan Tang2, Meng Shi3, Jun Liu4, Zhonghua Liu5, Xiaoliu Shi2, Yan Yi1.   

Abstract

Entities:  

Keywords:  chronic neutrophilic leukaemia; colony-stimulating factor 3 receptor; differential diagnosis; next generation sequencing; pathogenic mutation

Mesh：

Substances：

Year:  2016        PMID： 27984641     DOI： 10.1111/bjh.14456

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  STAT5BN642H is a driver mutation for T cell neoplasia.

Authors:  Ha Thi Thanh Pham; Barbara Maurer; Michaela Prchal-Murphy; Reinhard Grausenburger; Eva Grundschober; Tahereh Javaheri; Harini Nivarthi; Auke Boersma; Thomas Kolbe; Mohamed Elabd; Florian Halbritter; Jan Pencik; Zahra Kazemi; Florian Grebien; Markus Hengstschläger; Lukas Kenner; Stefan Kubicek; Matthias Farlik; Christoph Bock; Peter Valent; Mathias Müller; Thomas Rülicke; Veronika Sexl; Richard Moriggl
Journal:  J Clin Invest       Date:  2017-12-04       Impact factor: 14.808

Review 2.  STAT5A and STAT5B-Twins with Different Personalities in Hematopoiesis and Leukemia.

Authors:  Barbara Maurer; Sebastian Kollmann; Judith Pickem; Andrea Hoelbl-Kovacic; Veronika Sexl
Journal:  Cancers (Basel)       Date:  2019-11-04       Impact factor: 6.639

Review 3.  Chronic Neutrophilic Leukemia: A Comprehensive Review of Clinical Characteristics, Genetic Landscape and Management.

Authors:  Thomas P Thomopoulos; Argiris Symeonidis; Alexandra Kourakli; Sotirios G Papageorgiou; Vasiliki Pappa
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

4.  Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring CSF3R-T618I mutation with bilateral renal abscesses.

Authors:  Naohi Sahara; Kazuaki Yokoyama; Takashi Matsunaga; Shinsuke Kitahara; Tomoki Fujii; Seiichiro Kobayashi; Nozomi Yusa; Eigo Shimizu; Seiya Imoto; Arinobu Tojo; Nobuhiro Ohno
Journal:  Leuk Res Rep       Date:  2022-09-06

Review 5.  Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?

Authors:  Klara Klein; Dagmar Stoiber; Veronika Sexl; Agnieszka Witalisz-Siepracka
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 6.  STAT5 as a Key Protein of Erythropoietin Signalization.

Authors:  Zuzana Tóthová; Jana Tomc; Nataša Debeljak; Peter Solár
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 7.  Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.

Authors:  Elvin D de Araujo; Anna Orlova; Heidi A Neubauer; Dávid Bajusz; Hyuk-Soo Seo; Sirano Dhe-Paganon; György M Keserű; Richard Moriggl; Patrick T Gunning
Journal:  Cancers (Basel)       Date:  2019-11-08       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.